Source | Evidence on protein | Close homologs |
---|---|---|
Cuervo et al. | no | yes: 0 |
Hassani et al. | no | yes: 0 |
Forrest at al. (metacyclic) | no | yes: 0 |
Forrest at al. (procyclic) | no | yes: 0 |
Silverman et al. | no | yes: 0 |
Pissara et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Pires et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Silverman et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Jamdhade et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
DeepLoc | ||
SignalP6 | no | yes: 0, no: 1 |
NetGPI | no | yes: 0, no: 1 |
Related structures:
AlphaFold database: A4HN13
Term | Name | Level | Count |
---|---|---|---|
GO:0006950 | response to stress | 2 | 2 |
GO:0006979 | response to oxidative stress | 3 | 2 |
GO:0009987 | cellular process | 1 | 2 |
GO:0033554 | cellular response to stress | 3 | 2 |
GO:0034599 | cellular response to oxidative stress | 4 | 2 |
GO:0042221 | response to chemical | 2 | 2 |
GO:0050896 | response to stimulus | 1 | 2 |
GO:0051716 | cellular response to stimulus | 2 | 2 |
GO:0062197 | cellular response to chemical stress | 4 | 2 |
GO:0070887 | cellular response to chemical stimulus | 3 | 2 |
Term | Name | Level | Count |
---|---|---|---|
GO:0003824 | catalytic activity | 1 | 2 |
GO:0004601 | peroxidase activity | 2 | 2 |
GO:0005488 | binding | 1 | 2 |
GO:0016209 | antioxidant activity | 1 | 2 |
GO:0016491 | oxidoreductase activity | 2 | 2 |
GO:0016684 | oxidoreductase activity, acting on peroxide as acceptor | 3 | 2 |
GO:0020037 | heme binding | 4 | 2 |
GO:0046906 | tetrapyrrole binding | 3 | 2 |
GO:0097159 | organic cyclic compound binding | 2 | 2 |
GO:1901363 | heterocyclic compound binding | 2 | 2 |
Leishmania | From | To | Domain/Motif | Score |
---|---|---|---|---|
CLV_NRD_NRD_1 | 60 | 62 | PF00675 | 0.815 |
CLV_PCSK_KEX2_1 | 59 | 61 | PF00082 | 0.828 |
CLV_PCSK_SKI1_1 | 105 | 109 | PF00082 | 0.833 |
DEG_Nend_UBRbox_2 | 1 | 3 | PF02207 | 0.804 |
DOC_CYCLIN_yClb1_LxF_4 | 170 | 176 | PF00134 | 0.766 |
DOC_MAPK_gen_1 | 38 | 47 | PF00069 | 0.828 |
DOC_USP7_MATH_1 | 177 | 181 | PF00917 | 0.745 |
DOC_USP7_MATH_2 | 142 | 148 | PF00917 | 0.808 |
LIG_APCC_ABBA_1 | 47 | 52 | PF00400 | 0.812 |
LIG_BRCT_BRCA1_1 | 7 | 11 | PF00533 | 0.783 |
LIG_deltaCOP1_diTrp_1 | 16 | 25 | PF00928 | 0.794 |
LIG_FHA_1 | 131 | 137 | PF00498 | 0.834 |
LIG_LIR_Apic_2 | 16 | 22 | PF02991 | 0.789 |
LIG_LIR_Gen_1 | 174 | 184 | PF02991 | 0.750 |
LIG_LIR_Gen_1 | 8 | 17 | PF02991 | 0.782 |
LIG_LIR_Nem_3 | 174 | 179 | PF02991 | 0.750 |
LIG_LIR_Nem_3 | 8 | 14 | PF02991 | 0.783 |
LIG_MLH1_MIPbox_1 | 7 | 11 | PF16413 | 0.783 |
LIG_Pex14_1 | 164 | 168 | PF04695 | 0.812 |
LIG_REV1ctd_RIR_1 | 22 | 31 | PF16727 | 0.814 |
LIG_SH2_CRK | 176 | 180 | PF00017 | 0.745 |
LIG_SH2_NCK_1 | 176 | 180 | PF00017 | 0.745 |
LIG_SH2_STAT5 | 10 | 13 | PF00017 | 0.677 |
LIG_SH2_STAT5 | 4 | 7 | PF00017 | 0.785 |
LIG_SUMO_SIM_anti_2 | 152 | 158 | PF11976 | 0.790 |
LIG_SUMO_SIM_par_1 | 43 | 48 | PF11976 | 0.825 |
MOD_CK1_1 | 51 | 57 | PF00069 | 0.809 |
MOD_CK1_1 | 78 | 84 | PF00069 | 0.846 |
MOD_CK1_1 | 86 | 92 | PF00069 | 0.707 |
MOD_GlcNHglycan | 29 | 32 | PF01048 | 0.819 |
MOD_GlcNHglycan | 72 | 75 | PF01048 | 0.834 |
MOD_GlcNHglycan | 96 | 100 | PF01048 | 0.824 |
MOD_N-GLC_1 | 78 | 83 | PF02516 | 0.841 |
MOD_N-GLC_2 | 93 | 95 | PF02516 | 0.838 |
MOD_Plk_4 | 194 | 200 | PF00069 | 0.807 |
TRG_DiLeu_BaEn_1 | 9 | 14 | PF01217 | 0.783 |
TRG_ENDOCYTIC_2 | 10 | 13 | PF00928 | 0.782 |
TRG_ENDOCYTIC_2 | 176 | 179 | PF00928 | 0.746 |
TRG_ER_diArg_1 | 59 | 61 | PF00400 | 0.828 |